BILIRUBIN CONJUGATED INCREASED side effect
What is BILIRUBIN CONJUGATED INCREASED ?Drugs associated with BILIRUBIN CONJUGATED INCREASED
AMOCLAV ATAZANAVIR AUGMENTIN AVELOX AVIDART AVODART AVONEX BETAFERON BETASERON CALCIUM CANCIDAS CAPTOPRIL CHANTIX CLARITHROMYCIN CYCLOSPORINE DIOVAN DOXORUBICIN EMTRIVA EPIVIR ETOPOSIDE EXJADE FLUVASTATIN FORTUM INFERGEN INTERFERON KETEK LAMISIL LANSAP LEVAQUIN LOVENOX MALARONE MERCAPTOPURINE NELARABINE NISIS OLMESARTAN OXALIPLATIN PAXIL PEGINTERFERON REQUIP SEBIVO SEROQUEL SORAFENIB STRONTIUM TACROLIMUS TAVANIC THYMOGLOBULIN TRUVADA TYKERB VINCRISTINE ZANTAC ZOLPIDEMBILIRUBIN CONJUGATED INCREASED : Mercaptopurine Side Effects Report #5648022-7
Consumer or non-health professional from UNITED STATES reported MERCAPTOPURINE problem on Feb 29, 2008. Male patient, weighting 249.6 lb, was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, hepatic cirrhosis, ill-defined disorder, iron overload, transaminases increased, . MERCAPTOPURINE dosage: 5800 MG. During the same period patient was treated with VINCRISTINE SULPHATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Atazanavir Side Effects Report #5584372-0
ATAZANAVIR SULPHATE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 04, 2008. Female patient, 14 years of age, weighting 61.73 lb, was diagnosed with hiv infection and was treated with ATAZANAVIR SULPHATE. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, hyperbilirubinaemia, jaundice, . ATAZANAVIR SULPHATE dosage: unknown. During the same period patient was treated with STAVUDINE, LAMIVUDINE, BACTRIM, LASIX, ALDACTONE, LOSEC I. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Atazanavir Side Effects Report #5598845-8
Health Professional from UNITED STATES reported ATAZANAVIR SULPHATE problem on Jan 14, 2008. Female patient, 14 years of age, weighting 108.0 lb, was diagnosed with hiv infection and was treated with ATAZANAVIR SULPHATE. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, hyperbilirubinaemia, . ATAZANAVIR SULPHATE dosage: unknown. During the same period patient was treated with STAVUDINE, LAMIVUDINE, BACTRIM. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Avidart Side Effects Report #5602516-9
AVIDART problem was reported by a Physician from SPAIN on Jan 21, 2008. Male patient, 62 years of age, was treated with AVIDART. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, . AVIDART dosage: unknown. During the same period patient was treated with LIPEMOL, ALLOPURINOL. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Sebivo Side Effects Report #5504045-X
Consumer or non-health professional from CHINA reported SEBIVO problem on Oct 24, 2007. Female patient was diagnosed with hepatitis b and was treated with SEBIVO. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, cholelithiasis, mobility decreased, pain, poor quality sleep, protein total decreased, pruritus, . SEBIVO dosage: 600 MG, QD. During the same period patient was treated with HUGANNING, URSO FALK, ORYZANOL. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Sebivo Side Effects Report #5504693-7
SEBIVO problem was reported by a Consumer or non-health professional from CHINA on Oct 24, 2007. Female patient was diagnosed with hepatitis b and was treated with SEBIVO. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, cholelithiasis, mobility decreased, pain, poor quality sleep, protein total decreased, pruritus, . SEBIVO dosage: 600 MG, QD. During the same period patient was treated with HUGANNING, URSO FALK, ORYZANOL. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Avodart Side Effects Report #5508787-1
Consumer or non-health professional from FRANCE reported AVODART problem on Nov 02, 2007. Male patient, 91 years of age, was diagnosed with prostatic adenoma and was treated with AVODART. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, hepatitis cholestatic, jaundice cholestatic, . AVODART dosage: .5MG PER DAY. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Calcium Side Effects Report #5512584-0
CALCIUM problem was reported by a Physician from GERMANY on Nov 02, 2007. Female patient, 54 years of age, weighting 130.1 lb, was diagnosed with hyperparathyroidism, gastrointestinal stromal tumour and was treated with CALCIUM. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood creatinine increased, bone pain, fatigue, hypercalcaemia, malignant neoplasm progression, nausea, renal failure acute, vomiting, . CALCIUM dosage: unknown. During the same period patient was treated with ROCALTROL. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Levaquin Side Effects Report #5519080-5
Pharmacist from UNITED STATES reported LEVAQUIN problem on Nov 09, 2007. Female patient was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, . LEVAQUIN dosage: unknown. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Malarone Side Effects Report #5520856-9
MALARONE problem was reported by a Physician from FRANCE on Nov 12, 2007. Male patient, 24 years of age, was diagnosed with malaria prophylaxis and was treated with MALARONE. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, c-reactive protein increased, chills, eosinophil count increased, haemoglobin decreased, influenza like illness, lymphocyte count decreased, . MALARONE dosage: unknown. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Tavanic Side Effects Report #5524598-5
Health Professional from FRANCE reported TAVANIC problem on Nov 12, 2007. Male patient, 42 years of age, was diagnosed with sepsis and was treated with TAVANIC. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, blood lactate dehydrogenase increased, c-reactive protein increased, glucose-6-phosphate dehydrogenase deficiency, glycogen storage disease type i, haemolytic anaemia, platelet count increased, . TAVANIC dosage: unknown. During the same period patient was treated with GENTAMICIN. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Cancidas Side Effects Report #5492923-X
CANCIDAS problem was reported by a Consumer or non-health professional from SPAIN on Sept 14, 2007. Female patient, 50 years of age, was diagnosed with lower respiratory tract infection fungal, aplastic anaemia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, jaundice, respiratory failure, . CANCIDAS dosage: 70 MG/DAILY IV. During the same period patient was treated with CYCLOSPORINE, SULFAMETHOXAZOLE TRIMETHOPRIM, MYOLASTAN, NAPROXEN. Patient was hospitalized. Patient died.
BILIRUBIN CONJUGATED INCREASED : Sorafenib Side Effects Report #5492931-9
Physician from UNITED STATES reported SORAFENIB problem on Oct 16, 2007. Male patient, 67 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer, chronic obstructive pulmonary disease, obsessive-compulsive disorder and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood alkaline phosphatase increased, blood calcium decreased, blood phosphorus increased, blood urea nitrogen/creatinine ratio increased, condition aggravated, effusion, haematocrit decreased, haemoglobin decreased, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, NASAL OXYGEN, NASAL OXYGEN, NASAL OXYGEN, ZOLOFT. Patient was hospitalized. Patient died on 10/13/2007.
BILIRUBIN CONJUGATED INCREASED : Truvada Side Effects Report #5448038-X
TRUVADA problem was reported by a Health Professional from FRANCE on Aug 29, 2007. Male patient was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, eosinophilia, jaundice cholestatic, liver disorder, pyrexia, . TRUVADA dosage: unknown. During the same period patient was treated with VIRAMUNE. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Seroquel Side Effects Report #5460338-6
Health Professional from UNITED STATES reported SEROQUEL problem on June 29, 2007. Male patient, 46 years of age, was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, . SEROQUEL dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ACCUPRIL, GABAPENTIN, LAMICTAL, NEXIUM. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Cancidas Side Effects Report #5468674-4
CANCIDAS problem was reported by a Consumer or non-health professional from SPAIN on Sept 14, 2007. Female patient, 50 years of age, was diagnosed with lower respiratory tract infection fungal, aplastic anaemia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, jaundice, respiratory failure, . CANCIDAS dosage: 70 MG/DAILY IV. During the same period patient was treated with CYCLOSPORINE, SULFAMETHOXAZOLE TRIMETHOPRIM, MYOLASTAN, NAPROXEN. Patient was hospitalized. Patient died.
BILIRUBIN CONJUGATED INCREASED : Amoclav Side Effects Report #5406076-7
Physician from GERMANY reported AMOCLAV problem on Aug 01, 2007. Male patient, 55 years of age, was treated with AMOCLAV. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood alkaline phosphatase increased, blood cholesterol increased, blood lactate dehydrogenase increased, diarrhoea, gamma-glutamyltransferase increased, hepatic enzyme increased, hyperbilirubinaemia, jaundice, . AMOCLAV dosage: 1000MG TWICE PER DAY. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Diovan Side Effects Report #5408066-7
DIOVAN problem was reported by a Physician from CHINA on Aug 01, 2007. Male patient, 76 years of age, weighting 114.6 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, . DIOVAN dosage: 80 MG, QD. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Oxaliplatin Side Effects Report #5415369-9
Health Professional from UNITED STATES reported OXALIPLATIN problem on Aug 14, 2007. Female patient, 70 years of age, weighting 112.0 lb, was diagnosed with carcinoid tumour of the appendix and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, culture positive, enterococcal infection, escherichia infection, granulocytes abnormal, haematoma infection, haemoglobin decreased, jaundice, . OXALIPLATIN dosage: 365MG INTRAPERITONEAL. During the same period patient was treated with LISINOPRIL, FOSAMAX, CENTRUM, ASPIRIN, FOLIC ACID. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Clarithromycin Side Effects Report #5425375-6
CLARITHROMYCIN problem was reported by a Pharmacist from UNITED KINGDOM on Aug 14, 2007. Male patient, weighting 92.15 lb, was diagnosed with lower respiratory tract infection, sickle cell anaemia with crisis, pain, constipation and was treated with CLARITHROMYCIN. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, jaundice, . CLARITHROMYCIN dosage: unknown. During the same period patient was treated with MORPHINE, PARACETAMOL, CEFUROXIME, IBUPROFEN, LACTULOSE. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Diovan Side Effects Report #5426292-8
Physician from CHINA reported DIOVAN problem on Aug 20, 2007. Male patient, 76 years of age, weighting 114.6 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, gamma-glutamyltransferase increased, jaundice, . DIOVAN dosage: 80 MG, QD. During the same period patient was treated with ISOSORBIDE DINITRATE, DIURETICS. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Zantac Side Effects Report #5436021-X
ZANTAC problem was reported by a Pharmacist from JAPAN on Aug 28, 2007. Male patient, 55 years of age, weighting 154.5 lb, was diagnosed with gastritis and was treated with ZANTAC. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, blood bilirubin unconjugated increased, hepatitis, liver disorder, . ZANTAC dosage: unknown. During the same period patient was treated with FLUMARIN, NEOLAMIN, SOLDEM. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Thymoglobulin Side Effects Report #5423755-6
Health Professional from UNITED STATES reported THYMOGLOBULIN problem on July 15, 2004. Male patient, 13 years of age, was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, graft versus host disease, obliterative bronchiolitis, obstructive airways disorder, . THYMOGLOBULIN dosage: unknown. Patient died on 07/06/2004.
BILIRUBIN CONJUGATED INCREASED : Thymoglobulin Side Effects Report #5423755-6
THYMOGLOBULIN problem was reported by a Health Professional from UNITED STATES on July 15, 2004. Male patient, 13 years of age, was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, graft versus host disease, obliterative bronchiolitis, obstructive airways disorder, . THYMOGLOBULIN dosage: unknown. Patient died on 07/06/2004.
BILIRUBIN CONJUGATED INCREASED : Infergen Side Effects Report #5642248-4
Health Professional from UNITED STATES reported INFERGEN problem on Jan 28, 2008. Male patient, weighting 226.0 lb, was diagnosed with hepatitis c and was treated with INFERGEN. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, bilirubin conjugated increased, blood chloride increased, blood creatinine increased, blood glucose increased, blood iron increased, blood triglycerides increased, blood urea increased, blood uric acid increased, . INFERGEN dosage: unknown. During the same period patient was treated with RIBAVIRIN, ASPIRIN, TOPROL, LISINOPRIL, ZOLOFT, PLAVIX. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Vincristine Side Effects Report #5615476-1
VINCRISTINE problem was reported by a Consumer or non-health professional from FRANCE on Jan 25, 2008. Male patient, 17 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: aplasia, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, cholestasis, gamma-glutamyltransferase increased, hepatosplenic candidiasis, immune reconstitution syndrome, pyrexia, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE, CYTARABINE, PREDNISONE. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Zolpidem Side Effects Report #5534678-6
Health Professional from FRANCE reported ZOLPIDEM TARTRATE problem on Nov 23, 2007. Female patient, 79 years of age, was treated with ZOLPIDEM TARTRATE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bilirubin conjugated increased, blood bilirubin increased, cholelithiasis, jaundice cholestatic, . ZOLPIDEM TARTRATE dosage: unknown. During the same period patient was treated with ACARBOSE, FORLAX, LOVENOX, OGAST, LEVOTHYROX, NITRIDERM, DIFFU K, DEROXAT. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Tykerb Side Effects Report #5563046-6
TYKERB problem was reported by a Health Professional from UNITED STATES on Dec 07, 2007. Female patient, 52 years of age, weighting 145.3 lb, was diagnosed with breast cancer, back pain and was treated with TYKERB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bilirubin conjugated increased, blood bilirubin increased, dyspepsia, jaundice, nausea, . TYKERB dosage: 1250MG PER DAY. During the same period patient was treated with XELODA, IBUPROFEN, ENZYMES, GLUCOSAMINE, CALCIUM, ACIDOPHILUS, OMEGA. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Lovenox Side Effects Report #5576628-2
Health Professional from UNITED STATES reported LOVENOX problem on Dec 14, 2007. Male patient, 74 years of age, was diagnosed with asthma, hypertension, coronary artery disease and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, bilirubin conjugated increased, hepatic enzyme increased, . LOVENOX dosage: unknown. During the same period patient was treated with ADVAIR DISKUS, LOTREL, HYDROCHLOROTHIAZIDE, GLYBERIDE, SIMVASTATIN, FLOMAX, PLAVIX, ASPIRIN. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Lamisil Side Effects Report #5551676-7
LAMISIL problem was reported by a Physician from UNITED STATES on Nov 14, 2006. Female patient, 54 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, chromaturia, hepatic enzyme increased, pruritus, . LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Fortum Side Effects Report #5443395-2
Pharmacist from FRANCE reported FORTUM problem on Sept 04, 2007. Male patient, weighting 7.72 lb, was diagnosed with sepsis, pain, antifungal prophylaxis and was treated with FORTUM. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic enzyme abnormal, transaminases increased, . FORTUM dosage: 60MG THREE TIMES PER DAY. During the same period patient was treated with AMOXICILLIN, CLAFORAN, GENTAMICIN, AMIKLIN, PARACETAMOL, VITAMINS, FUNGIZONE, CIFLOX. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Exjade Side Effects Report #5467758-4
EXJADE problem was reported by a Pharmacist from FRANCE on Sept 19, 2007. Male patient, 28 years of age, weighting 119.0 lb, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: anaemia, bilirubin conjugated increased, blood bilirubin increased, blood cholesterol decreased, cytolytic hepatitis, dyspnoea exertional, folate deficiency, haemoglobin decreased, headache, . EXJADE dosage: 1000 MG, QD. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Nelarabine Side Effects Report #5470544-2
Pharmacist from UNITED STATES reported NELARABINE problem on Sept 27, 2007. Male patient, weighting 187.4 lb, was diagnosed with t-cell lymphoma refractory and was treated with NELARABINE. After drug was administered, patient experienced the following problems/side effects: aggression, bilirubin conjugated increased, blood bilirubin increased, cerebellar infarction, confusional state, csf white blood cell count positive, disorientation, hepatic enzyme increased, international normalised ratio increased, . NELARABINE dosage: 1275 MG DAILY X 5 DAYS IV. During the same period patient was treated with BACTRIM DS, LOVENOX, AMLODIPINE, GRANISETRON, ESOMEPRAZOLE MAGNESIUM, DIPHENHYDRAMINE, MORPHINE, NIFEDIPINE. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Exjade Side Effects Report #5403589-9
EXJADE problem was reported by a Pharmacist from FRANCE on July 27, 2007. Male patient, 28 years of age, weighting 119.0 lb, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: anaemia, bilirubin conjugated increased, blood bilirubin increased, blood cholesterol decreased, cytolytic hepatitis, dyspnoea exertional, folate deficiency, haemoglobin decreased, headache, . EXJADE dosage: 1000 MG, QD. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Exjade Side Effects Report #5404819-X
Pharmacist from FRANCE reported EXJADE problem on July 27, 2007. Male patient, 28 years of age, weighting 119.0 lb, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: anaemia, bilirubin conjugated increased, blood bilirubin increased, blood cholesterol decreased, cytolytic hepatitis, dyspnoea exertional, folate deficiency, haemoglobin decreased, headache, . EXJADE dosage: 1000 MG, QD. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Ketek Side Effects Report #5430700-6
KETEK problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2007. Male patient was treated with KETEK. After drug was administered, patient experienced the following problems/side effects: ascites, bilirubin conjugated increased, gamma-glutamyltransferase increased, hepatotoxicity, jaundice, liver disorder, portal hypertension, splenomegaly, . KETEK dosage: unknown. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Oxaliplatin Side Effects Report #5431691-4
Physician from UNITED STATES reported OXALIPLATIN problem on Aug 23, 2007. Female patient, 70 years of age, weighting 112.0 lb, was diagnosed with carcinoid tumour of the appendix and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal adhesions, bilirubin conjugated increased, central line infection, haemoglobin decreased, intestinal obstruction, leukocytosis, neutropenia, pelvic haematoma, pelvic infection, . OXALIPLATIN dosage: unknown. During the same period patient was treated with FOLIC ACID, ASPIRIN, CENTRUM, FOSAMAX, LISINOPRIL. Patient was hospitalized. Patient died on 08/13/2007.
BILIRUBIN CONJUGATED INCREASED : Fortum Side Effects Report #5386597-6
FORTUM problem was reported by a Pharmacist from FRANCE on July 12, 2007. Female patient, weighting 7.72 lb, was diagnosed with sepsis and was treated with FORTUM. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase decreased, . FORTUM dosage: 60MG THREE TIMES PER DAY. During the same period patient was treated with AMOXICILLIN, CLAFORAN, GENTAMICIN, AMIKLIN, VITAMIN. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Cyclosporine Side Effects Report #5393812-1
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on July 13, 2007. Male patient was diagnosed with histiocytosis haematophagic and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: ascites, bilirubin conjugated increased, blood bilirubin increased, blood creatinine increased, blood pressure increased, blood urea increased, cardiac failure congestive, cardiomegaly, . CYCLOSPORINE dosage: 3 MG/KG/D. During the same period patient was treated with PREDONINE, ACYCLOVIR. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Cyclosporine Side Effects Report #5394178-3
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on July 13, 2007. Male patient was diagnosed with histiocytosis haematophagic and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: ascites, bilirubin conjugated increased, blood bilirubin increased, blood creatinine increased, blood pressure increased, blood urea increased, cardiac failure congestive, cardiomegaly, . CYCLOSPORINE dosage: 3 MG/KG/D. During the same period patient was treated with PREDONINE, ACYCLOVIR. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Fortum Side Effects Report #5386597-6
Pharmacist from FRANCE reported FORTUM problem on July 12, 2007. Female patient, weighting 7.72 lb, was diagnosed with sepsis and was treated with FORTUM. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase decreased, . FORTUM dosage: 60MG THREE TIMES PER DAY. During the same period patient was treated with AMOXICILLIN, CLAFORAN, GENTAMICIN, AMIKLIN, VITAMIN. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Cyclosporine Side Effects Report #5393812-1
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on July 13, 2007. Male patient was diagnosed with histiocytosis haematophagic and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: ascites, bilirubin conjugated increased, blood bilirubin increased, blood creatinine increased, blood pressure increased, blood urea increased, cardiac failure congestive, cardiomegaly, . CYCLOSPORINE dosage: 3 MG/KG/D. During the same period patient was treated with PREDONINE, ACYCLOVIR. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Cyclosporine Side Effects Report #5394178-3
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on July 13, 2007. Male patient was diagnosed with histiocytosis haematophagic and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: ascites, bilirubin conjugated increased, blood bilirubin increased, blood creatinine increased, blood pressure increased, blood urea increased, cardiac failure congestive, cardiomegaly, . CYCLOSPORINE dosage: 3 MG/KG/D. During the same period patient was treated with PREDONINE, ACYCLOVIR. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Tacrolimus Side Effects Report #5646591-4
TACROLIMUS problem was reported by a Physician from UNITED STATES on Feb 20, 2008. Female patient, child 12 years of age, was diagnosed with stem cell transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood albumin decreased, blood bilirubin increased, blood cholesterol increased, blood triglycerides increased, chronic graft versus host disease, gamma-glutamyltransferase increased, . TACROLIMUS dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, PENTAMIDINE ISETHIONATE, AMPHOTERICIN B, ACYCLOVIR, ESCITALOPRAM OXALATE, MYCOPHENOLATE MOFETIL. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Requip Side Effects Report #5651059-5
Physician from JAPAN reported REQUIP problem on Feb 27, 2008. Female patient, 82 years of age, weighting 116.8 lb, was diagnosed with parkinson's disease, bronchitis, gastritis and was treated with REQUIP. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, body temperature, c-reactive protein increased, . REQUIP dosage: 4MG TWICE PER DAY. During the same period patient was treated with CARBIDOPA AND LEVODOPA, SYMMETREL, SELEGILINE, MUCODYNE, SELBEX, CABERGOLINE. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Chantix Side Effects Report #5656673-9
CHANTIX problem was reported by a Pharmacist from UNITED STATES on Mar 06, 2008. Male patient was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, chills, nausea, pyrexia, viral infection, . CHANTIX dosage: 1MG TWICE DAILY PO. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Thymoglobulin Side Effects Report #5677839-8
Physician from UNITED STATES reported THYMOGLOBULIN problem on Dec 07, 2006. Female patient, 60 years of age, weighting 227.1 lb, was diagnosed with liver transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, haemangioma of liver, hepatic artery stenosis, . THYMOGLOBULIN dosage: 159 MG, QD, INTRAVENOUS; 80 MG, QD, INTRAVENOUS; 85.5 MG, QD, INTRAVENOUS; 75 MG, QD, INTRAVENOUS. During the same period patient was treated with TACROLIMUS, MYCOPHENOLATE MOFETIL, BACTRIM DS, VALCYTE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Epivir Side Effects Report #5692274-4
EPIVIR problem was reported by a Physician from KOREA, REPUBLIC OF on Mar 20, 2008. Female patient, 47 years of age, was diagnosed with hepatitis b and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood albumin decreased, blood bilirubin increased, dermatitis, haemoglobin decreased, haemorrhage, prothrombin time prolonged, . EPIVIR dosage: unknown. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Requip Side Effects Report #5621964-4
Physician from JAPAN reported REQUIP problem on Feb 07, 2008. Female patient, 82 years of age, weighting 116.8 lb, was diagnosed with parkinson's disease, bronchitis, gastritis and was treated with REQUIP. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, body temperature, c-reactive protein increased, . REQUIP dosage: 4MG TWICE PER DAY. During the same period patient was treated with CARBIDOPA AND LEVODOPA, SYMMETREL, SELEGILINE, MUCODYNE, SELBEX, CABERGOLINE. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Peginterferon Side Effects Report #5623894-0
PEGINTERFERON ALFA problem was reported by a Physician from CHINA on Jan 31, 2008. Male patient, 27 years of age, weighting 149.9 lb, was diagnosed with hepatitis b and was treated with PEGINTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, condition aggravated, fatigue, . PEGINTERFERON ALFA dosage: unknown. Patient was hospitalized. Patient recovered.
BILIRUBIN CONJUGATED INCREASED : Nisis Side Effects Report #5636334-2
Physician from FRANCE reported NISIS problem on Feb 14, 2008. Female patient, 74 years of age, was diagnosed with hypertension and was treated with NISIS. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, asthenia, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood glucose increased, gamma-glutamyltransferase increased, hepatitis, jaundice, . NISIS dosage: 80 MG, QD. Patient was hospitalized. Patient recovered.